Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndromeFrancesco Ciccia(University of Palermo), G Triolo(University of Palermo)Lara D. VeekenMarch 6, 201410.1093/rheumatology/keu004Cited by 51SaveCiteExport RISWatch citationsRelated PapersInterleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis|Arthritis & Rheumatism|2011|128Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity|Lara D. Veeken|2014|15